Efficacy and Safety of Tildrakizumab for Treatment of Moderate-to-Severe Scalp Psoriasis in Patients with Obesity Over 52 Weeks

• by Howard L. Sofen, Ranga Gogineni, Tushar Nishandar, Jerry Bagel

• May 9, 2026

Triglycerides Linked to Psoriasis Risk

Genetically predicted triglyceride levels were associated with higher odds of psoriasis, while genetically predicted total fatty acid levels were not, in a two-sample Mendelian randomization analysis.

• by Andrea Surnit

• June 26, 2026

• 4 min

Pediatric Psoriasis: Comorbidities, Treatment Challenges and Unmet Needs

• by Marc Hernández-Santacana, Pablo Balado-Simó, Miguel Mansilla-Polo, Josep Riera-Monroig

• July 7, 2026

The Circadian Skin: Chronobiology as a New Frontier in Dermatological Therapy

• by Diala Haykal

• September 7, 2026